Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jovan P Antovic

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|September 30, 2003
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assayJovan P Antovic, Aleksandra Antovic
Thrombosis Research|August 8, 2002
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutationJovan P Antovic, Margareta Blombäck
Seminars in Thrombosis and Hemostasis|February 12, 2026
Extracellular Vesicles Drive Coagulopathy Across Hematologic CancersCharlotte Gran, Sanna Norén, Jovan P Antovic
Seminars in Thrombosis and Hemostasis|April 14, 2026
The Role of Circulating Extracellular Vesicles in HemophiliaRoza Chaireti, Jovan P Antovic, Iva Pruner
Journal of Cardiovascular Development and Disease|July 25, 2022
Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving RivaroxabanMojca Božič Mijovski, Jovan P Antovic, Rickard E Malmström, et al.
Thrombosis Research|May 28, 2013
Pneumatic tube transport affects platelet function measured by multiplate electrode aggregometrySimon Thalén, Ida Forsling, Jaak Eintrei, et al.
Thrombosis Research|May 5, 2007
Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndromeMika Skeppholm, N Håkan Wallén, Karin Malmqvist, et al.
Scientific Reports|March 16, 2021
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generationMojca Božič Mijovski, Rickard E Malmström, Nina Vene, et al.
Thrombosis and Haemostasis|November 22, 2013
Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demandAleksandra Antovic, Danijela Mikovic, Ivo Elezovic, et al.
Journal of Electrocardiology|January 6, 2020
Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiographyYanan Zong, Maren Maanja, Roza Chaireti, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|September 30, 2003
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assayJovan P Antovic, Aleksandra Antovic
Thrombosis Research|August 8, 2002
Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutationJovan P Antovic, Margareta Blombäck
Seminars in Thrombosis and Hemostasis|February 12, 2026
Extracellular Vesicles Drive Coagulopathy Across Hematologic CancersCharlotte Gran, Sanna Norén, Jovan P Antovic
Seminars in Thrombosis and Hemostasis|April 14, 2026
The Role of Circulating Extracellular Vesicles in HemophiliaRoza Chaireti, Jovan P Antovic, Iva Pruner
Journal of Cardiovascular Development and Disease|July 25, 2022
Biological Variation in Rotational Thromboelastometry in Patients with Atrial Fibrillation Receiving RivaroxabanMojca Božič Mijovski, Jovan P Antovic, Rickard E Malmström, et al.
Thrombosis Research|May 28, 2013
Pneumatic tube transport affects platelet function measured by multiplate electrode aggregometrySimon Thalén, Ida Forsling, Jaak Eintrei, et al.
Thrombosis Research|May 5, 2007
Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndromeMika Skeppholm, N Håkan Wallén, Karin Malmqvist, et al.
Scientific Reports|March 16, 2021
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generationMojca Božič Mijovski, Rickard E Malmström, Nina Vene, et al.
Thrombosis and Haemostasis|November 22, 2013
Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demandAleksandra Antovic, Danijela Mikovic, Ivo Elezovic, et al.
Journal of Electrocardiology|January 6, 2020
Substantial prevalence of subclinical cardiovascular diseases in patients with hemophilia A evaluated by advanced electrocardiographyYanan Zong, Maren Maanja, Roza Chaireti, et al.
Pageof 4